Publications
237
Citations
25,809
Est. group size
—
Recurring co-author estimate
Active years
51
Publishing since 1976
Richard Fishel's research focuses on DNA repair mechanisms, particularly how proteins like MSH and MutS/MutL detect and fix errors in DNA using single-molecule imaging and biophysical techniques. His lab also investigates colorectal cancer biology, including how immune signaling pathways (cGAS/STING) and certain drugs can enhance cancer immunotherapy responses. This work combines molecular biophysics with cancer genomics to understand both fundamental DNA repair processes and their relevance to cancer treatment.
Publication output has fluctuated over the last decade but shows an increase in recent years, with notably higher output in 2021, 2025, and 2026 compared to earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Single-trajectory Bayesian modeling reveals multi-state diffusion of the MSH sliding clamp
npj Systems Biology and Applications · 2026
- Supplementary Figure 5 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2026
- Supplementary Figure 4 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2026
- Supplementary Figure 2 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2026
- Supplementary Figure 1 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2026
- Supplementary Figure 3 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2026
- A high-throughput single-molecule platform to study DNA supercoiling effect on protein–DNA interactions
Nucleic Acids Research · 2025
- An Accessible Python Framework for Real-Time Magnetic Tweezers Microscope Control and Image Processing
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Supplementary Figure 2 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Supplementary Figure 3 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Supplementary Figure 5 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Supplementary Figure 1 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Supplementary Methods from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Supplementary Figure 4 from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- Data from Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
2025
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Biophysical Journal×6
- Nature Communications×4
- Journal of Biological Chemistry×4
- Proceedings of the National Academy of Sciences×3
- Alexis Chassen
Medicine · The Ohio State University
- Marie‐Véronique Poirier
Medicine · The Ohio State University
- Rachel Pearlman
Medicine · The Ohio State University
- Heather Hampel
Medicine · The Ohio State University
- Maegan E. Roberts
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile